| ADH | alcohol dehydrogenase |
| ADME | absorption, distribution, metabolism, and excretion (in this review, the fourth process is treated as clearance-like removal, since in vitro skin models have no excretory function) |
| AHT | 4-amino-2-hydroxytoluene |
| AMT | total cumulative amount permeated |
| BCRP | breast cancer resistance protein |
| CBM | cutaneous biodistribution method |
| COMT | catechol-O-methyltransferase |
| CRS | confocal Raman spectroscopy |
| CYP | cytochrome P450 |
| dOFM | dermal open-flow microperfusion |
| EFSA | European Food Safety Authority |
| EHS | ex vivo human skin |
| EMA | European Medicines Agency |
| ER | electrical resistance |
| FDA | U.S. Food and Drug Administration |
| FMO | flavin-containing monooxygenase |
| FTSE | full-thickness skin equivalent |
| GelMA | gelatin methacryloyl |
| GST | glutathione S-transferase |
| HPLC | high-performance liquid chromatography |
| IVIVE | in vitro–in vivo extrapolation |
| IVPT | in vitro permeation testing |
| IVRT | in vitro release testing |
| LC–MS | liquid chromatography–mass spectrometry |
| LSE | living skin equivalent |
| MALDI | matrix-assisted laser desorption/ionization |
| MIVO | multi-in-vitro-organ (microphysiological platform) |
| MPS | microphysiological system |
| MRP | multidrug resistance-associated protein |
| MSI | mass spectrometry imaging |
| NAT | N-acetyltransferase |
| OECD | Organisation for Economic Co-operation and Development |
| PBPK | physiologically based pharmacokinetic |
| PDMS | poly(dimethylsiloxane) |
| P-gp | P-glycoprotein |
| RHE | reconstructed human epidermis |
| SC | stratum corneum |
| TEWL | transepidermal water loss |
| TG | Test Guideline |
| UGT | UDP-glucuronosyltransferase |
| UHPLC–MS/MS | ultra-high-performance liquid chromatography–tandem mass spectrometry |
| XME | xenobiotic-metabolizing enzyme |
| A | exposed diffusion area |
| Cd | dissolved donor concentration in contact with the barrier |
| Cin, Cout | compound concentration in the inlet and outlet perfusate |
| CLapp | apparent concentration-normalized clearance |
| Cref | concentration in the compartment from which the compound is removed |
| Deff | effective diffusion coefficient |
| Jmax | maximum flux |
| Jpeak | peak flux under finite-dose conditions |
| Jss | steady-state flux |
| Kp | apparent permeability coefficient |
| Q(t) | cumulative amount permeated per unit area |
| Qf | volumetric flow rate |
| Sv | saturation solubility of the compound in the applied vehicle |
| tlag | lag time |
| tpeak | time of peak flux |